| |
| |
|
| Insider
Information: |
Lenz Brian |
| Relationship: |
|
| City: |
Monmouth Junction |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
739,002 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$6,486,613 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
739,002 |
|
|
| Total
Value |
$6,486,613 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
4
|
2
|
|
Stock
price went up :
|
2
|
2
|
| Stock
price went down : |
2
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
| Percentage
Gain/Loss : |
 -1.1%
|
 105.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vioquest Pharmaceuticals |
VOQP |
CFO and Treasurer |
2008-01-14 |
15,000 |
2005-12-09 |
0 |
Premium* |
|
|
Arno therapeutics Inc |
ARNI |
Chief Financial Officer |
2008-09-08 |
4,000 |
2008-09-08 |
0 |
Premium* |
|
|
Cormedix Inc. |
CRMD |
CFO, TREASURER & SECRE... |
2011-12-14 |
17,000 |
2010-03-30 |
0 |
Premium* |
|
|
ADMA Biologics Inc |
ADMA |
|
2024-03-07 |
703,002 |
2013-10-22 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
44 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VOQP |
Vioquest Pharmaceuticals |
officerTitle |
• – – |
2005-12-09 |
4 |
B |
$0.80 |
$4,000 |
D/D |
5,000 |
5,000 |
2.66 |
- |
|
| VOQP |
Vioquest Pharmaceuticals |
CFO and Treasurer |
• – – |
2008-01-14 |
4 |
B |
$0.12 |
$1,208 |
D/D |
10,000 |
15,000 |
2.66 |
- |
|
| ARNI |
Arno therapeutics Inc |
Chief Financial Officer |
• – – |
2008-09-08 |
4 |
A |
$3.00 |
$6,000 |
D/D |
2,000 |
2,000 |
0 |
- |
|
| ARNI |
Arno therapeutics Inc |
Chief Financial Officer |
• – – |
2008-09-08 |
4/A |
B |
$3.00 |
$12,000 |
D/D |
4,000 |
4,000 |
2.74 |
- |
|
| CRMD |
Cormedix Inc. |
Chief Financial Officer |
• – – |
2010-03-30 |
4 |
B |
$0.00 |
$0 |
D/D |
2,000 |
2,000 |
2.66 |
- |
|
| CRMD |
Cormedix Inc. |
Chief Financial Officer |
• – – |
2010-08-16 |
4 |
B |
$1.54 |
$1,540 |
D/D |
1,000 |
3,000 |
2.66 |
- |
|
| CRMD |
Cormedix Inc. |
CFO, TREASURER & SECRETARY |
• – – |
2011-12-14 |
4 |
B |
$0.33 |
$4,820 |
D/D |
14,000 |
17,000 |
2.66 |
- |
|
| ADMA |
ADMA Biologics Inc |
Chief Financial Officer |
• – – |
2013-10-22 |
4 |
B |
$8.50 |
$8,500 |
D/D |
1,000 |
1,000 |
2.74 |
- |
|
| ADMA |
ADMA Biologics Inc |
Chief Financial Officer |
• – – |
2014-05-14 |
4 |
B |
$7.50 |
$7,500 |
D/D |
1,000 |
2,000 |
2.74 |
- |
|
| ADMA |
ADMA Biologics Inc |
Chief Financial Officer |
• – – |
2014-05-22 |
4 |
B |
$8.06 |
$4,030 |
D/D |
500 |
2,500 |
2.66 |
- |
|
| ADMA |
ADMA Biologics Inc |
Chief Financial Officer |
• – – |
2014-08-13 |
4 |
B |
$9.80 |
$4,900 |
D/D |
500 |
3,000 |
2.66 |
- |
|
| ADMA |
ADMA Biologics Inc |
Chief Financial Officer |
• – – |
2015-03-16 |
4 |
B |
$7.97 |
$9,961 |
D/D |
1,250 |
4,250 |
2.74 |
- |
|
| ADMA |
ADMA Biologics Inc |
Chief Financial Officer |
• – – |
2015-03-19 |
4 |
B |
$8.82 |
$6,714 |
D/D |
750 |
5,000 |
2.74 |
- |
|
| ADMA |
ADMA Biologics Inc |
Chief Financial Officer |
• – – |
2015-12-02 |
4 |
B |
$9.14 |
$9,151 |
D/D |
1,000 |
6,000 |
2.74 |
- |
|
| ADMA |
ADMA Biologics Inc |
Chief Financial Officer |
• – – |
2016-05-03 |
4 |
B |
$6.50 |
$16,250 |
D/D |
2,500 |
8,500 |
2.74 |
- |
|
| ADMA |
ADMA Biologics Inc |
VP, CFO |
• – – |
2017-11-09 |
4 |
B |
$2.15 |
$13,975 |
D/D |
6,500 |
15,000 |
2.74 |
- |
|
| ADMA |
ADMA Biologics Inc |
VP, CFO |
• – – |
2018-06-08 |
4 |
B |
$4.78 |
$23,900 |
D/D |
5,000 |
20,000 |
2.74 |
- |
|
| ADMA |
ADMA Biologics Inc |
EVP, CFO |
• – – |
2019-05-17 |
4 |
B |
$4.00 |
$20,000 |
D/D |
5,000 |
25,000 |
2.74 |
- |
|
| ADMA |
ADMA Biologics Inc |
EVP, CFO |
• – – |
2020-02-11 |
4 |
B |
$3.50 |
$24,997 |
D/D |
7,142 |
32,142 |
2.74 |
% |
|
| ADMA |
ADMA Biologics Inc |
EVP, CFO |
• – – |
2020-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
72,142 |
0 |
- |
|
| ADMA |
ADMA Biologics Inc |
EVP, CFO |
• – – |
2020-08-11 |
4 |
B |
$2.97 |
$11,860 |
D/D |
4,000 |
76,142 |
2.74 |
% |
|
| ADMA |
ADMA Biologics Inc |
EVP, CFO |
• – – |
2021-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
63,936 |
140,078 |
0 |
- |
|
| ADMA |
ADMA Biologics Inc |
EVP, CFO |
• • – |
2021-09-29 |
4 |
A |
$0.00 |
$0 |
D/D |
900,000 |
1,035,501 |
0 |
- |
|
| ADMA |
ADMA Biologics Inc |
EVP, CFO |
• • – |
2021-10-25 |
4 |
B |
$1.00 |
$30,000 |
D/D |
30,000 |
1,065,501 |
0.01 |
% |
|
| ADMA |
ADMA Biologics Inc |
EVP, CFO |
• • – |
2022-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
137,500 |
1,190,653 |
0 |
- |
|
44 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
